Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2016

View Archived Issues

Vaxil Bio completes reverse takeover transaction

Microbion and Haisco enter agreement to develop and commercialize MBN-101

Onxeo acquires DNA Therapeutics, provides update on Validive development plan

CAMH and Impel NeuroPharma sign licensing agreement for neuropeptide treatment for depression

Anti-sclerostin antibody from Mereo granted U.S. orphan status for osteogenesis imperfecta

CSIR reports development of anticancer agents

Oxalate descarboxylase receives FDA orphan drug designation for pediatric hyperoxaluria

Alkem Laboratories discloses cathepsin K inhibitors

Clinical candidate GDC-0326 identified from novel, selective PI3Kalpha inhibitors

Amgen files for FDA approval of Blincyto for pediatric Ph-negative B-cell precursor ALL

GlycoMimetics announces initial clinical data from phase I trial of GMI-1271 in AML

EyeGate receives additional milestone payment for the development of EGP-437

Baxalta submits MAA for Adynovi for the treatment of hemophilia A

Nuvo Research completes reorganization

Merck Patent and Cancer Research Technology describe CDK8/cyclin C inhibitors

Johns Hopkins University patent reveals UAP inhibitors

Arromax Pharmatech divulges protein kinase inhibitors

Ixodes in SPA agreement with FDA on phase III trial of Ixogel to prevent Lyme disease

GEFs as strong prognostic markers of cancer progression

DDIT4 gene is a marker for outcomes in multiple cancer types

Otonomy launches Otiprio in U.S.

TiGenix seeks European approval for Cx-601

Phase II trial of danegaptide for cardiac reperfusion injuries does not meet primary endpoint

Interim data from phase IIb trial of VT-1161 in onychomycosis

C4X Discovery acquires Adorial and its subsidiaries

Genetic variability of SCN4A is associated with essential tremor

Cynata Therapeutics enters preliminary agreement for strategic alliance with Regience in Japan

Voclosporin receives FDA fast track designation for the treatment of lupus nephritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...